Journal of Clinical Virology PlusVolume 2, Issue 3, August 2022, 100097Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three casesAuthor links open overlay panelDaniele Focosi a, Federica Novazzi b d, Andreina Baj b d, Francesca Drago Ferrante b, Sara Boutahar b d, Angelo Paolo Genoni b d, Daniela Dalla Gasperina c d, Fabrizio Maggi b dShow moreShareCitehttps://doi.org/10.1016/j.jcvp.2022.100097Get rights and contentUnder a Creative Commons licenseopen accessPrevious article in issueNext article in issueKeywordsSARS-CoV-2OmicronSpike: E340SotrovimabRecommended articlesCited by (0)© 2022 The Authors. Published by Elsevier Ltd.